0001140361-17-047643.txt : 20171228
0001140361-17-047643.hdr.sgml : 20171228
20171228183857
ACCESSION NUMBER: 0001140361-17-047643
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20171213
FILED AS OF DATE: 20171228
DATE AS OF CHANGE: 20171228
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: CPMG Inc
CENTRAL INDEX KEY: 0001372218
STATE OF INCORPORATION: TX
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37785
FILM NUMBER: 171279403
BUSINESS ADDRESS:
STREET 1: 2000 MCKINNEY
STREET 2: SUITE 2125
CITY: DALLAS
STATE: TX
ZIP: 75201
BUSINESS PHONE: 214-871-6816
MAIL ADDRESS:
STREET 1: 2000 MCKINNEY
STREET 2: SUITE 2125
CITY: DALLAS
STATE: TX
ZIP: 75201
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: REATA PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001358762
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 113651945
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2801 GATEWAY DRIVE SUITE 150
CITY: IRVING
STATE: TX
ZIP: 75063
BUSINESS PHONE: 972-865-2206
MAIL ADDRESS:
STREET 1: 2801 GATEWAY DRIVE SUITE 150
CITY: IRVING
STATE: TX
ZIP: 75063
4/A
1
form4.xml
X0306
4/A
2017-12-13
2017-12-15
0001358762
REATA PHARMACEUTICALS INC
RETA
0001372218
CPMG Inc
2000 MCKINNEY AVE., STE 2125
DALLAS
TX
75201
true
true
Class A common stock
2017-12-13
4
P
0
19982
24.8838
A
19982
I
By Managed Account for Trustees of the University of Pennsylvania
Class A common stock
2017-12-13
4
P
0
49
23.9767
A
20031
I
By Managed Account for Trustees of the University of Pennsylvania
Class A common stock
2017-12-14
4
P
0
14866
24.6528
A
34897
I
By Managed Account for Trustees of the University of Pennsylvania
Class A common stock
442560
I
By Gallopavo, LP
This price reflects the weighted average purchase price for open-market purchases on December 13, 2017, within a $1.00 range. The actual prices for these transactions range from $24.08 to $25.08 inclusive. The Reporting Person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares purchased at each separate price within the ranges set forth in footnotes (1), (2) and (3) to this Form 4.
This price reflects the weighted average purchase price for open-market purchases on December 13, 2017, within a $1.00 range. The actual prices for these transactions range from $23.97 to $23.99 inclusive.
This price reflects the weighted average purchase price for open-market purchases on December 14, 2017, within a $1.00 range. The actual prices for these transactions range from $24.40 to $24.92, inclusive.
The Reporting Person is the investment manager of each of Gallopavo, LP and a managed account for Trustees of the University of Pennsylvania. The Reporting Person disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
On December 15, 2017, the Reporting Persons inadvertently reported that these shares were purchased for the account of Gallopavo, LP. As correctly noted on this amendment, the shares were purchased for a managed account for Trustees of the University of Pennsylvania. Gallopavo, LP has not engaged in trades since the report filed by the Reporting Persons on June 23, 2017.
Mr. McGaughy, Jr., a co-director and co-shareholder of the Reporting Person, serves on the Issuer's Board of Directors (the "Board") as a representative of the Reporting Person. By virtue of his representation on the Board, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the Reporting Person is deemed to be a director by deputization.
/s/ John Bateman, Chief Operating Officer of CPMG, Inc.
2017-12-28